SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

CAC 40 NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

Sanofi-Aventis: Click to view the issuer\'s details

Last update : 29/03/2019  >View issuer details

2020.11.23 | 22:08 | Share Buybacks / Share redemption disclosures

English version HTML (w) Mail

puce Sanofi: Disclosure of trading in own shares - HTML (w)

2020.11.23 | 22:08 | Share Buybacks / Share redemption disclosures

French version HTML (w) Mail

puce Sanofi : Déclaration des transactions sur actions propres - HTML (w)

2020.11.18 | 07:15 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Rilzabrutinib granted FDA Fast Track Designation for treatment of immune thrombocytopenia - HTML (w)

2020.11.18 | 07:15 | Permanent Information Releases / General Company News

French version HTML (w) Mail

puce La FDA accorde une procédure accélérée au rilzabrutinib pour le traitement de la thrombocytopénie immune - HTML (w)

2020.11.18 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce FDA grants priority review for avalglucosidase alfa, a potential new therapy for Pompe disease - HTML (w)

2020.11.02 | 07:15 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products - HTML (w)

2020.10.29 | 14:50 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce European Patent Office rules in favor of Sanofi and Regeneron concerning Praluent® (alirocumab) - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 2994